glp 1 patches drug interactions GLP-1 and Telehealth Weight Loss Care IUPHAR review – Glucagon-like peptide-1
Description
Additionally, the bodys metabolic rate tends to decrease following weight loss, triggering processes that promote weight regain
The first and last authors had access to all the data and had final responsibility for the decision to submit for publication
Obes Rev
Other second-line options for patients who cannot tolerate or fail to respond to metformin and topiramate are the glucagon-like peptide-1 (GLP-1) receptor agonists
Disclaimer: This post is intended solely for educational and informational purposes
Janoshik testing in progress
